BIG PHARMA EARNINGS WATCH: GSK, PFIZER, MERCK, BRISTOL MYERS SQUIBB
Aug 7, 2024
Big Pharma Continues Raking in Expectation-Beating Profits and Revenue Fueled… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRxP APPLAUDS REINTRODUCTION OF REMEDY ACT IN U.S. SENATE
Jul 31, 2024
Bipartisan, Market-Based Solution Would Help Crack Down on Anti-Competitive… Read More
BIG PHARMA EARNINGS: SANOFI, ASTRAZENECA, ROCHE AND ABBVIE
Jul 26, 2024
More Brand Name Drug Makers Beat Wall Street Earnings After Hiking Prices This… Read More
BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS
Jul 23, 2024
Big Pharma Giants Top Wall Street Expectations After Hiking Prices on… Read More
CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES
Jul 15, 2024
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More
ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN
Jul 15, 2024
Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma… Read More
CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Jul 11, 2024
Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics… Read More
NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Jul 2, 2024
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More
SECOND OPINION: LATEST PHRMA AD CAMPAIGN DEFENDS PATENT ABUSE “STATUS QUO”
Jun 26, 2024
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More
DOSE OF REALITY: FORBES: HOW BIG PHARMA EXPLOITS LOOPHOLES IN THE PATENT SYSTEM
Jun 25, 2024
Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny… Read More
SECOND OPINION: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS ARE THE ROOT CAUSE OF HIGH DRUG PRICES
Jun 17, 2024
Breaking Down the Facts on Drug Prices, Innovation, Patent Abuse… Read More
DOSE OF REALITY: FORBES: MAKING IT HARDER TO CHALLENGE BIG PHARMA’S PATENT THICKETS WOULD RAISE DRUG PRICES, UNDERMINE TRUE INNOVATION
Jun 5, 2024
Research Article Explores Negative Implications of Proposal to Restrict Key… Read More